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Airway abnormalitiesAbstract Background: The diagnosis in cases of mediastinal and hilar lymphadenitis without
parenchymal involvement of the lung is often difﬁcult. Mediastinal lymphadenopathy may be
due to a variety of benign or malignant reasons. Hence, it is important to establish a diagnosis
and differentiate benign from malignant lymph nodes.
Aim of the work: To study the usefulness of ﬁberoptic bronchoscopy in diagnosis of patients with
mediastinal lymphadenopathy.
Patients and methods: The present study included 30 patients with mediastinal lymphadenopa-
thy. All were subjected to written informed consent, full history taking, full clinical examination,
tuberculin skin test, chest X-ray and CT chest. Fiberoptic bronchoscopy including autoﬂuorescence
bronchoscopy with mucosal biopsies, TBNA and bronchial lavage were also obtained.
Results: 46.7% of the study patients were diagnosed as malignancy, 20% diagnosed as sarcoid-
osis, 10% diagnosed as TB, 3.33% diagnosed as reactive lymphadenitis and 20% were undiagnosed.
Observed anatomical airway abnormalities included vocal cord paralysis (16.7%), tracheal com-
pression (3.3%), widening of main or second carina (80%) and mucosal abnormalities (46.7%)
in the form of nodules, inﬁltration with tumour tissue and unhealthy mucosa. Bronchial mucosal
biopsy was the most useful method of diagnosis (56.7%) followed by TBNA (30%) and ﬁnally
BAL (13.3%). AFB has no cost effective value over WLB in detection of malignant lesions.
278 K. Eid et al.Conclusion: The best diagnostic yield was obtained by combination of bronchial mucosal biopsy
and TBNA techniques.
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Tuberculosis.Introduction
Mediastinal lymphadenopathy is a common clinical condition
encountered by chest physicians. Lymph nodes may be
enlarged due to a variety of benign or malignant reasons.
Hence, it is important to establish a diagnosis and differentiate
benign from malignant lymph nodes [1].
The diagnosis in cases of mediastinal and hilar lymphadeni-
tis without parenchymal involvement of the lung is often
difﬁcult. There are many causes of mediastinal and hilar lym-
phadenopathy, including infection, neoplasm, granulomatous
disease and reactive hyperplasia. Chest radiographs and com-
puted tomography (CT) have become the standard technique
for demonstration of mediastinal and hilar lymphadenopathy
and in many cases biopsy is required to establish the speciﬁc
diagnosis [2].
The mechanisms responsible for the airway involvement are
diverse. The entire spectrum of the airways from the nasal and
oral passages to terminal bronchioles can be affected. The
anatomic abnormalities may include extrinsic compression of
airways by the enlarged lymph nodes, various types of mucosal
involvement, luminal stenosis and airway distortion caused by
parenchymal changes [3].
Bronchoscopy is an invaluable diagnostic tool for many
lung disorders and a safe procedure with low (0.1–2.5%) mor-
bidity and very low (0.05%) mortality. Conventional trans-
bronchial needle aspiration (TBNA) has probably been the
most important innovation to the ancillary diagnostic devices
(forceps biopsy, bronchial brushing, bronchoalveolar lavage
and bronchial washings), as it created the possibility of sam-
pling beyond the wall of the central airways. The quality of
the diagnostic bronchoscopic examination is certainly operator
dependent, but the pathological analysis and interpretation of
the acquired samples is also of eminent importance in the diag-
nostic process [4].
The aim of the present study was to assess the value of
ﬁberoptic bronchoscopy in diagnosis of mediastinal lymphad-
enopathy, with special emphasis on:
 Anatomical airway abnormalities (extra luminal compres-
sion, widening of the carina, mucosal nodules, unhealthy
mucosa, etc.).
 The best sampling method for pathological diagnosis
(mucosal biopsy, TBNA and BAL).
 The role of AFB in detection of mucosal abnormalities in
patients with mediastinal lymphadenopathy.Subjects
The present study was conducted in the Chest Department in
collaboration with the Pathology Department, Kasr Alainy
Hospital, Cairo University. The study included 30 patientswith mediastinal lymphadenopathy. Patients who were unﬁt
for bronchoscopy, e.g., patients with refractory hypoxia not
responding to oxygen therapy, acute hypercapnia or bleeding
disorders were excluded from the study.
Methods
All included individuals were subjected to written informed
consent, detailed history taking, full clinical examination, rou-
tine chemical and haematological blood analysis including
complete blood count, and coagulation proﬁle, arterial blood
gases, tuberculin skin test, plain chest X-ray (P-A view) and
CT chest with IV contrast. Fiberoptic bronchoscopy (FOB)
(PENTAX FB18RX, Ashi Optical, Japan) including autoﬂuo-
rescence (SAFE 1000, Ashi Optical, Japan) bronchoscopy with
mucosal biopsies, TBNA and bronchial lavage were also done
to all included patients.
Fiberoptic bronchoscopy
Patients were fasting for at least 6 h and intravenous access
was insured. 0.5–1 mg atropine sulphate was given intramuscu-
lar, half an hour before the procedure to reduce the bronchial
secretions and suppress vagal overactivity. FOB was per-
formed via the nasal route. Lidocaine 2% was given as local
anaesthetic agent. The patient’s pulse oximetry, heart rate
and blood pressure were monitored throughout the procedure
to ensure adequate oxygenation and hemodynamic stability.
Steps of the procedure
After insertion of FOB and visualization of vocal cords, sys-
tematic inspection of the tracheobronchial tree was done, with
identiﬁcation of sites of lesions, such as: widening of the main
or secondary carina, extra luminal compression, mucosal
abnormalities (e.g., nodules, inﬁltration with tumour tissue
or unhealthy mucosa).
Autoﬂuorescence bronchoscopy was done routinely after
white light bronchoscopy (WLB) to identify sites of abnormal
mucosa which was apparently normal by WLB. Abnormal
mucosa shows a cold image due to lack of autoﬂuorescence.
Neoplastic tissues can be distinguished from surrounding nor-
mal tissues by their properties of ﬂuorescence when exposed to
blue light [5].
TBNA was performed using a 21-gauge cytology needle
consisting of a 140 cm long ﬂexible catheter and a system of
21-G ‘‘pull-out’’ needles. It was performed before any other
sampling technique in order to eliminate the possibility of con-
tamination or changing the stage of the tumour in cases of sus-
pected malignancy. The needle system was advanced through
the working channel of the bronchoscope with the needle
pulled out in the catheter. When the metallic tip of the catheter
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advanced and drilled the tracheal or bronchial wall at the tar-
get site. 20 ml syringe was used for applying suction to the
proximal edge thus ensuring the safety of the drill site. Under
continuous suction, the needle was successively pushed in and
pulled out (few millimetres) 4–5 times so that an adequate sam-
ple was obtained. Suction had been discontinued before the
needle was pulled out from the target site. The edge of the
bronchoscope was aligned and the system was removed from
the bronchoscope with a gentle manoeuvre. The sample
obtained was spread on clean, dry glass slides and immediately
ﬁxed by 70% alcohol solution and sent for cytological exami-
nation. The procedure was repeated 4–6 times (Fig. 1) [6].
BAL: During standard ﬂexible bronchoscopy, the broncho-
scope is placed in a wedge position within the selected
bronchopulmonary segment (basal segment of right lower
lobe, if no abnormal segment detected). Normal saline (at
room temperature) is instilled through the bronchoscope, with
a total volume of 100–300 ml and divided into three to ﬁve ali-
quots. After the instillation of each aliquot, instilled saline is
generally retrieved using a negative suction pressure less than
100 mmHg. For optimal sampling of distal airspaces, the total
volume retrieved should beP30% of the total instilled volume
to avoid increased risk of tissue disruption and/or inﬂamma-
tory mediator release due to over distension of the lavaged seg-
ment. An amount of 50 ml of BAL sample was sent for
cytological examination [7].
Mucosal biopsies: Multiple mucosal biopsies were obtained
using crocodile 18 mm biopsy forceps, introduced through the
working channel of the bronchoscope. Site of biopsiesFigure 1 Autoﬂuorescence bronchoscopy.included, the mucosa overlying the widened ridges, the
unhealthy and inﬁltrated mucosa as seen by WLB or AFB
and from the healthy mucosa if no detected abnormal mucosa.
Biopsies were immediately immersed in 10% formalin solution
and sent for histopathological examination.
Histopathological technique: Tissue samples were ﬁxed in
10% neutral buffered formalin for 24 h and then underwent
routine processing and wax embedding. Sections (5 lm thick)
were stained with haematoxylin and eosin (H&E). The smears
taken from TBNA and BAL were stained with the Papanico-
laou (PAP) stain as well as the H&E stains [8].
Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), median and range, or frequencies (number
of cases) and percentages when appropriate. Comparison of
numerical variables between the study groups was done using
Kruskal Wallis test. For comparing categorical data, Chi
square (v2) test was performed. Exact test was used instead
when the expected frequency is less than 5. P values less than
0.05 were considered statistically signiﬁcant. All statistical cal-
culations were done using computer programs SPSS (Statisti-
cal Package for the Social Science; SPSS Inc., Chicago, IL,
USA) version 15 for Microsoft Windows.
Results
The present study included 30 patients who fulﬁlled the
selection criteria and formed the study population. According
to ﬁnal histopathological results, 14 (46.7%) patients were
diagnosed as malignancy, 6 (20%) patients diagnosed as
sarcoidosis, 3 (10%) patients diagnosed as tuberculous
lymphadenopathy, 3.33% cases diagnosed as reactive lym-
phadenopathy and 6 (20%) patients were undiagnosed (Fig. 2).
According to the demographics of the study population,
there was a statistically signiﬁcant difference in the mean age
between malignancy (55 ± 12.66), sarcoidosis (35.33 ± 6.25)
and tuberculosis (58 ± 8.19) patients. Regarding sex distribu-
tion, all malignant patients were males and all sarcoidosis and
tuberculosis patients were females. The difference in sex
distribution was found to be statistically signiﬁcant. Regarding
special habits 13 patients (43.3%) were smokers, 12 of them
were diagnosed as malignancy and 1 patient was diagnosed
as reactive lymphadenitis. Also 8 patients (26.7%) were raising
birds, 4 of them were diagnosed as sarcoidosis, 1 patient was46.7%
3%
20%
10%
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lymphadenis"
"
"
"
"
Sarcoidosis
TB
Undiagnosed
Figure 2 Distribution of ﬁnal diagnosis.
280 K. Eid et al.diagnosed as tuberculosis and 3 patients undiagnosed. The rest
of patients did not have any special habits (Table 1).
Anatomical airway abnormalities encountered during FOB
included (Table 2): vocal cord paralysis in 5 patients (16.7%), 4
(80%) of them were diagnosed as malignancy and 1 patient
was undiagnosed; tracheal compression in 1 patient (3.3%)
and he was diagnosed as malignancy; abnormal mucosa in
14 patients (46.7%), 9 of them were diagnosed as malignancy,
2 were diagnosed as sarcoidosis and 2 were diagnosed as TB
(Fig. 3) and 1 was undiagnosed.
Regarding the effect of lymph node enlargement on the air-
ways, it was unilateral in 15 patients, 9 of them were malignant
(64.3% of malignant cases) and bilateral airway affection was
found in 9 patients, 4 of them were diagnosed as sarcoidosis
(66.6% of sarcoidosis cases). The difference between unilateral
and bilateral effect was statistically non signiﬁcant. Also the
effect of lymph node enlargement on the airways, was central
(involving trachea and main carina) in 24 patients, 12 of them
were diagnosed as malignant (85.7% of malignant cases) and 6
of them were diagnosed as sarcoidosis (100% of sarcoidosisTable 2 Anatomical airway abnormalities and effect of L.N enlarg
Final diagnosis
Malignancy
(n= 14)
Sarcoidosis
(n= 6)
Vocal cord paralysis (count, % within
ﬁnal diagnosis)
4 (28.6%) 0 (0.0%)
Tracheal compression (count, % within
ﬁnal diagnosis)
1 (7.1%) 0 (0.0%)
Mucosal abnormality (nodules, inﬁltration and
unhealthy mucosa) (count, % within
ﬁnal diagnosis)
9 (64.3%) 2 (33.3%)
Eﬀect of enlarged L.N on the airways
Unilateral 9 (64.3%) 1 (16.7%)
Bilateral 2 (14.3%) 4 (66.7%)
Normal airways 3 (21.4%) 1 (16.7%)
Eﬀect of enlarged L.N on the airways
Central (trachea and main carina) 12 (85.7%) 6 (100.0%)
Peripheral (2nd carina) 11 (78.6%) 5 (83.3%)
Table 1 Patient characteristics in relation to ﬁnal diagnosis.
Final diagnosis
Malignancy
(n= 14)
Sarcoidosis
(n= 6)
Tuberculosi
(n= 3)
Sex distribution (count, % within ﬁnal diagnosis)
Female 0 (0.0%) 6 (100.0%) 3 (100.0%)
Male 14 (100.0%) 0 (0.0%) 0 (0.0%)
Age (mean ± SD) (years) 55 ± 12.66 35.33 ± 6.25 58 ± 8.19
Special habits (count, % within subgroup)
Smoking 12 (85.7%) 0 (0.0%) 0 (0.0%)
Raising birds 0 (0.0%) 4 (66.9%) 1 (33.3%)
No special habits 2 (14.3%) 2 (33.3%) 2 (66.7%)
* P value is signiﬁcant at the level of <0.0.patients), while it was peripheral (involving the second carina,
lobar and segmental bronchi) in 24 patients, 11 of them were
diagnosed as malignant (78.6% of malignant cases), 5 of them
were diagnosed as sarcoidosis (83.3% of sarcoidosis patients)
and 2 patients were diagnosed as TB (66.7% of TB cases)
(Table 2).
Regarding the comparison between WLB and AFB, the
bronchial mucosa appeared abnormal by WLB in 14 patients
(46.7%), while it appeared abnormal by AFB in 17 patients
(56.7%). The difference between WLB and AFB ﬁndings
was found to be statistically insigniﬁcant (Table 3).
Histopathologically, mucosal biopsy results were positive in
17 patients (56.7%) out of the 30 patients forming the study
population, 10 of them were diagnosed as malignancy
(71.4% of the 14 malignant cases), 4 were diagnosed as sar-
coidosis (66.7% of the 6 sarcoidosis patients) and 3 were diag-
nosed as tuberculosis (100% of the 3 TB patients). Mucosal
biopsy results were found to be statistically signiﬁcant. TBNA
cytology results were positive in 9 patients (30%), 7 of them
were diagnosed as malignancy (50% of malignancy patients),ement on the airways during FOB in relation to ﬁnal diagnosis.
Total
(n= 30)
P-Value
Tuberculosis
(n= 3)
Reactive
lymphadenopathy
(n= 1)
Undiagnosed
(n= 6)
0 (0.0%) 0 (0.0%) 1 (16.7%) 5 (16.7%) 0.489
0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (3.3%) 0.881
2 (66.7%) 0 (0.0%) 1 (16.7%) 14 (46.7%) 0.200
1 (33.3%) 0 (0.0%) 4 (66.4%) 15 (50.0%) 0.161
1 (33.3%) 0 (0.0%) 2 (33.3%) 9 (30.0%)
1 (33.3%) 1 (100.0%) 0 (0.0%) 6 (20.0%)
0 (0.0%) 0 (0.0%) 6 (100.0%) 24 (80.0%) –
2 (66.7%) 0 (0.0%) 6 (100.0%) 24 (80.0%)
Total
(n= 30)
P-Value
s Reactive
Lymphadenopathy
(n= 1)
Undiagnosed
(n= 6)
0 (0.0%) 6 (100.0%) 15 (50.0%) 0.00*
1 (100.0%) 0 (0.0%) 15 (50.0%)
50.00 52.7 ± 10.5 50.77 ± 12.92 0.015*
1 (100.0%) 0 (0.0%) 13 (43.3%) 0.001*
0 (0.0%) 3 (50.0%) 8 (26.7%)
0 (0.0%) 3 (50.0%) 9 (30.0%)
Figure 3 Bronchoscopic view of mucosal nodules and biopsy
revealed caseating tuberculous granuloma.
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cytology results were diagnostic in 4 patients (13.3%) only;
all of them were diagnosed as malignancy (28.6% of malignant
cases). TBNA cytology results were found to be statistically
signiﬁcant while BAL cytology results were found to be statis-
tically insigniﬁcant (Table 4).
The total number of ﬁnally diagnosed cases was 23 patients
(14 malignancy, 6 sarcoidosis and 3 tuberculosis). Mucosal
biopsy was diagnostic in 17 (73.9%) patients. TBNA was diag-
nostic in 9 cases (39.1%) and BAL was diagnostic only in 4Table 4 Relationship between mucosal biopsy, TBNA cytology
population.
Final diagnosis
Malignancy
(n= 14)
Sarcoidosis
(n= 6)
Tuberculosis
(n= 3)
Reactiv
(n= 1)
Mucosal biopsy results (count, % within ﬁnal diagnosis)
Negative 4 (28.6%) 2 (33.3%) 0 (0.0%) 1 (100.
Positive 10 (71.4%) 4 (66.7%) 3 (100.0%) 0 (0.0%
TBNA cytology results (count, % within ﬁnal diagnosis)
Negative 7 (50.0%) 6 (100.0%) 1 (33.3%) 1 (100.
Positive 7 (50.0%) 0 (0.0%) 2 (66.7%) 0 (0.0%
BAL cytology results (count, % within ﬁnal diagnosis)
Negative 10 (71.4%) 6 (100.0%) 3 (100.0%) 1 (100.
Positive 4 (28.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%
* P value is signiﬁcant at the level of <0.05.
Table 3 Statistical comparison between WLB and AFB ﬁndings in
Final diagnosis
Malignancy
(n= 14)
Sarcoidosis
(n= 6)
T
(n
Abnormal mucosa by WLB
(count, % within ﬁnal diagnosis)
9 (64.3%) 2 (33.3%) 2
Abnormal mucosa by AFB
(count, % within ﬁnal diagnosis)
11 (78.6%) 2 (33.3%) 2
P-Value = 0.438 (non signiﬁcant).(17.4%) cases. The combination of mucosal biopsy and TBNA
increased the percentage of malignancy from 71.4% to 78.6%
of all diagnosed malignant cases (although statistical difference
between mucosal biopsy alone and the combination between
mucosal biopsy and TBNA was insigniﬁcant). The combina-
tion of mucosal biopsy and BAL does not increase the diag-
nostic value (no statistically signiﬁcant difference between
mucosal biopsy alone and this combination). The combination
of TBNA and BAL does not add any value to diagnosis by
TBNA alone. Also the diagnostic value of the combination
of mucosal biopsy, TBNA and BAL was equal to the diagnos-
tic value of the combination of mucosal biopsy and TBNA
(Table 5 and Fig 4).
The difference between mucosal biopsy results and the
cytology results of either TBNA or BAL alone or in combina-
tion was found to be statistically signiﬁcant (Table 6).
Discussion
There are many causes of mediastinal and hilar lymphadenop-
athy, including infection, neoplasm, granulomatous disease
and reactive hyperplasia. Infection consists predominantly of
tuberculosis and fungal infection. The neoplastic causes
include lymphoma, leukaemia and metastatic carcinoma. Sar-
coidosis is also a common cause of intra thoracic lymphade-
nopathy [2].
Bilateral symmetrical hilar lymphadenopathy is typical of
sarcoidosis, whereas it is bilateral but asymmetrical in, BAL cytology results and ﬁnal diagnosis within the study
Total
(n= 30)
P-Value
e lymphadenopathy Undiagnosed
(n= 6)
0%) 6 (100.0%) 13 (43.3%) 0.012*
) 0 (0.0%) 17 (56.7%)
0%) 6 (100.0%) 21 (70.0%) 0.038*
) 0 (0.0%) 9 (30.0%)
0%) 6 (100.0%) 26 (86.7%) 0.260
) 0 (0.0%) 4 (13.3%)
relation to ﬁnal diagnosis.
Total
(n= 30)
uberculosis
= 3)
Reactive
lymphadenopathy
(n= 1)
Undiagnosed
(n= 6)
(66.7%) 0 (0.0%) 1 (16.7%) 14 (46.7%)
(66.7%) 0 (0.0%) 2 (33.3%) 17 (56.7%)
Table 5 Diagnostic value of mucosal biopsy, TBNA, BAL and their combinations in relation to ﬁnal diagnosis.
Malignancy
(n= 14)
Sarcoidosis
(n= 6)
Tuberculosis
(n= 6)
Total
(n= 23)
Mucosal biopsy 10 (71.4%) 4 (66.7%) 3 (100%) 17 (73.9%)
TBNA 7 (50%) 0 (0%) 2 (66.7%) 9 (39.1%)
BAL 4 (28.6%) 0 (0%) 0 (0%) 4 (17.4%)
Mucosal biopsy + TBNA 11 (78.6%) 4 (66.7%) 3 (100%) 18 (78.3%)
Mucosal biopsy + BAL 10 (71.4%) 4 (66.7%) 3 (100%) 17 (73.9%)
TBNA+ BAL 7 (50%) 0 (0%) 2 (66.7%) 9 (39.1%)
Mucosal biopsy + TBNA+ BAL 11 (78.6%) 4 (66.7%) 3 (100%) 18 (78.3%)
Figure 4 Diagnostic value of the combinations of mucosal
biopsy, TBNA and BAL in relation to ﬁnal diagnosis.
282 K. Eid et al.lymphoma. Bilateral hilar lymphadenopathy in elderly could
be due to small cell carcinoma. Unilateral hilar lymphadenop-
athy could be due to tuberculosis in the young and metastases
from bronchogenic carcinoma in older people [9].
In the present study, the mean age of malignant patients was
55 years and this agreed with Bahader and Jazieh [10] who
found that mean age at diagnosis of lung cancer was 64 years
while the mean age for sarcoidosis cases was 35 years and this
agreed with Iannuzzi et al. [11] who mentioned that sarcoidosisTable 6 Statistical comparison between the diagnostic value of m
study.
Diagnostic
Mucosal biopsy 17
TBNA 9
Mucosal biopsy 17
BAL 4
TBNA 9
BAL 4
Mucosal biopsy 17
Mucosal biopsy + TBNA 18
Mucosal biopsy 17
Mucosal biopsy + BAL 17
Mucosal biopsy 17
TBNA+ BAL 9
Mucosal biopsy 17
TBNA 9
BAL 4
* P value is signiﬁcant at the level of <0.05.usually develops before the age of 50 years, with the incidence
peaking at 20–39 years. The mean age of TB lymphadenopathy
patients was found to be 58 years and this agreed with Khan
et al. [12] who found that ages of patients with TB mediastinal
lymphadenopathy ranged from 17 to 60 years.
In the present study, malignancy was almost exclusively in
males and this agreed with Bahader and Jazieh [10] who found
that lung cancer affected 75.6% of males and 24.4% of females
with male to female ratio of 3:1. Also Rabahi et al. [13] men-
tioned that there was a higher prevalence of lung cancer among
males, with a male to female ratio of 1.46:1.00. On the other
hand this study disagreed with Bain et al. [14] who found high
incidence of lung cancer among females. In the present study,
sarcoidosis was exclusive in females, and this agreed with Ian-
nuzzi et al. [11] who stated that a preponderance of cases of
sarcoidosis in females is consistent across racial and ethnic
groups. Also De Moraes et al. [15] reported that sarcoidosis
is prevalent in women, however Byg et al. [16] found that sar-
coidosis overall male to female ratio was 1.06. In the present
study, all patients with TB mediastinal lymphadenopathy were
females and this agreed with Chang et al. [17] who reported
that incidence of intra thoracic TB lymphadenopathy was
0.4% in males and 1% in females. But this study disagreed
with Khan et al. [12] who mentioned that the ratio of male
to female in patients with TB mediastinal lymphadenopathy
was 1.2.
Regarding special habits, 85% of malignancy cases were
smokers, this agreed with Silvestri et al. [18] who stated thatucosal biopsy, TBNA, BAL and their combinations within the
Non-diagnostic Total P-Value
13 30 0.0371*
21 30
13 30 0.0004*
26 30
21 30 0.1171
26 30
13 30 0.7934
12 30
13 30 No
13 30
13 30 0.0371*
21 30
13 30 0.0015*
21 30
26 30
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accounts for 85–90% of all cases. Also Sahin and Yildiz [19]
stated that all types of lung cancer were higher in the group
of smokers. 66.7% of sarcoidosis patients were raising birds
and this agreed with Rossman and Kreider [20] who stated that
exposures associated with sarcoidosis included bird exposure
and De Moraes et al. [15] who mentioned that sarcoidosis usu-
ally occurs in individuals exposed to environments in which
other granulomatoses are proven to occur, particularly, bird
raising and occupational exposure.
During FOB, 80% of cases with vocal cord paralysis were
found to be malignant. In contrast to this study, Myssiorek
[21] stated that mediastinal lymph node metastases represent
4% of the causes of vocal cord paralysis. Also Rabahi et al.
[13] found vocal fold paralysis in 3% only of the malignant
cases.
In the present study, 14 patients (46.7%) showed mucosal
abnormalities, 15 patients (50%) showed unilateral airway
affection, 9 patients (30%) showed bilateral airway affection,
24 patients (80%) showed central airway affection and 24
patients showed peripheral airway affection. Also Rai et al.
[2] mentioned that bronchoscopy showed abnormality in
39.6% of patients with mediastinal lymphadenopathy and
these abnormalities included widening of main carina in
12.5%, widening of secondary carina in 8.3%, bulge into air-
ways because of extrinsic compression in 14.6% and endo-
bronchial nodule in 4.2% of patients.
In this study, endobronchial abnormalities in patients with
malignant mediastinal lymph nodes included mucosal abnor-
malities in 9 cases (64.3%), unilateral airway affection in 9 cases
(64.3%), central airway affection in 12 patients (85.7%) and
peripheral airway affection in 11 patients (78.6%). This study
agreed with Bayram et al. [22] who reported that the most com-
mon endobronchial pathology in malignant cases was extrinsic
compression (25.5%) and mucosal abnormalities (43.5%). Also
Rabahi et al. [13] mentioned that cases of malignancy showed
mucosal inﬁltration in 35%, mucosal nodules in 2%, widening
of the main carina in 19%, external compression in 18% and
unhealthy mucosa in 87% of cases. Again Sahin and Yildiz
[19] reported that out of 485 patients with malignant mediasti-
nal lymph nodes undergoing bronchoscopy, 72.5% had muco-
sal abnormalities and 30% had the ﬁndings of external
pressure. Verma et al. [23] mentioned that the endoscopic
appearance of the visible lesions in patients with malignancy
was found in 100% of patients.
In the present study, the observed endobronchial abnor-
malities in sarcoidosis patients included; mucosal affection
(mainly nodules) in 33.3% of patients, widening of main carina
in 100% of patients, widening of second carina in 83.3% of
patients and this agreed with Armstrong et al. [24] who found
mucosal nodules in 64% and bronchostenosis in 26% of sar-
coidosis cases. Also Lannes et al. [25] observed enlargement
of main carina in 59%, enlargement of secondary carina in
16%, right or left paratracheal bulging in 7%, bulging on
the posterior trachea wall in 4%, bulging of the right or left
main bronchus in 7% and 7% of cases showed no abnormal-
ities. Also Matsuoka et al. [26] stated that endobronchial nod-
ules were found in 0–33% of sarcoidosis patients. In contrast
to this study Ishii et al. [27] study found no mucosal nodularity
or bronchial compression in sarcoidosis patients.
In this study, patients with TB lymphadenopathy showed
mucosal affection in 2 patients (66.7%) of TB cases andperipheral airway affection in 66.7% of cases. This agreed with
Chang et al. [17] who stated that endobronchial involvement
was found in 75% of patients with TB lymphadenopathy
who underwent bronchoscopic examination. Also Baran
et al. [28] found that 82.4% of patients with TB lymphadenop-
athy had an endobronchial abnormality, widened carina in
47.4%, bronchial or tracheal displacement by lymph node
enlargement in 41.2%. Again Ayed and Behbehani [29] found
that 20% of patients with intra thoracic TB lymphadenopathy
had an endobronchial abnormality.
In the present study, the difference between AFB (56.7%)
and WLB (46.7%) ﬁndings was insigniﬁcant. To the best of
our knowledge no studies were done to investigate the role
of AFB in cases of mediastinal lymphadenopathy, but there
were some studies which were performed on cases of lung can-
cer. Lam et al. [30] and Kusunoki et al. [31] found that speci-
ﬁcity of AFB to detect premalignant and malignant lesions was
relatively low and no signiﬁcant difference than WLB alone.
Hanibuchi et al. [5] stated that the sensitivity of AFB plus
WLB to detect premalignant lesions (95.7%) was signiﬁcantly
improved than using WLB alone (59.6%) whereas there was
no signiﬁcant difference between AFB plus WLB and WLB
alone in detecting non malignant lesions. Lam et al. [30] stated
that the combination of AFB/WLB can increase the diagnostic
yield of this invasive procedure.
In the present study, the histopathology of bronchial muco-
sal biopsy was diagnostic in 17 patients; 10 of them were diag-
nosed as malignancy (71.4% of the 14 malignant patients), 4
were diagnosed as sarcoidosis (66.7% of the 6 sarcoidosis
patients) and 3 were diagnosed as tuberculosis (100% of the
3 TB patients). Also Armstrong et al. [24] stated that endo-
bronchial biopsy of normal appearing airway was diagnostic
to sarcoidosis in 30–37% and Puar et al. [32] mentioned that
endobronchial biopsy technique may demonstrate non necro-
tizing granulomas in cases of sarcoidosis even if the airways
are normal on visual inspection and endobronchial biopsy
(EBB) resulted in diagnostic tissue in 50–70% of cases. Again
Shorr et al. [33] reported that EBB ﬁndings were positive in
61.8% of the patients with sarcoidosis and without the use
of EBB many cases would have been missed. In other words,
regular employment of EBB during FOB resulted in a 20.6%
increase in the value of the procedure. On the other hand, Ishii
et al. [27] mentioned that endobronchial biopsy of normal
appearing mucosa does not improve diagnostic capacity in
combination with other methods in sarcoidosis.
Chang et al. [17] stated that mucosal biopsy was used to
make a diagnosis of TB in 62.5% of patients with endobron-
chial abnormalities and bronchoscopy was used to make a
diagnosis of tuberculosis in 50% of cases in which broncho-
scopic ﬁndings were negative. Bayram et al. [22] stated that
bronchial forceps biopsy is the most frequently preferred pro-
cedure that has diagnostic rate around 76–82% in lung cancer.
Verma et al. [23] reported that histopathological examination
of bronchial biopsies yielded positive diagnosis in 81.6% of
cases having endoscopically visible tumors. Schenk et al. [34]
found that endobronchial biopsy afforded the highest yield
(56%) in patients with malignancy.
The present study results disagreed with Ayed and Behbeh-
ani [29] who found that mucosal samples taken from endo-
bronchial abnormality at bronchoscopy gave a deﬁnite
diagnosis in 9% of TB endobronchial abnormality. So they
concluded that bronchoscopy has a low diagnostic yield in
284 K. Eid et al.mediastinal tuberculous lymphadenopathy in the absence of a
parenchymal lesion.
In this study, the TBNA cytology results were diagnostic in
9 (30%) patients; 7 of them were diagnosed as malignancy
(50% of malignancy patients), 2 were diagnosed as tuberculo-
sis (66.7% of TB cases) and none of sarcoidosis patients were
diagnosed by TBNA. This agreed with Bilaceroglu et al. [35]
who stated that TBNA provided positive results in 83% of
patients with intra thoracic TB lymphadenopathy, but they
also reported positive results in 80% of patients with non
tuberculous adenopathy. Also Cetinkaya et al. [36] found that
diagnosis was made by TBNA in 65% of tuberculosis patients
and 100% of patients with carcinoma. Again, the present study
agreed with Lannes et al. [25] who stated that sarcoidosis can
only be deﬁnitively diagnosed through the detection of non
caseous granuloma and TBNA with a ﬁne needle plays a
limited role in the diagnosis of the disease. Using TBNA con-
comitantly with transbronchial biopsy or even bronchial
biopsy improves diagnostic efﬁciency. Also Bayram et al.
[22] reported that TBNA procedure was positive in 76% of
cases with mediastinal and hilar lymph nodes in lung cancer.
Szlubowski et al. [37] found that the TBNA technique was
diagnostic in 67.1% of lung cancer patients with mediastinal
lymph nodes and Punamiya et al. [38] stated that TBNA is
highly speciﬁc for detecting mediastinal lymph node metastasis
in patients with NSCLC.
On the other hand, this study disagreed with Bilaceroglu
et al. [35] who reported a diagnostic yield between 42% and
90% for TBNA in patients with stage I and II sarcoidosis
(in hilar and/or mediastinal lymph nodes) and in 14–20% of
patients, it was the only technique to provide a histologic diag-
nosis. Also Cetinkaya et al. [36] found that diagnosis was made
by TBNA in 76% of cases with sarcoidosis. Similarly, Ferna´n-
dez-Villar et al. [39] reported that TBNA alone detected sar-
coid granulomas in 61.5% of patients, and it was the only
technique to do so in 30.8% of patients.
As regards BAL cytology results, it was observed that BAL
was diagnostic in only a small portion (28.6%) of malignant
cases. This study agreed with Gaur et al. [40] who found that
BAL cytology showed 14.3% true positive cases and 57.1%
true negative cases, as conﬁrmed by biopsy. Also Leonard
et al. [41] found that 36.4% of patients with positive biopsies
had negative BAL, underlining the poor sensitivity of BAL
in sarcoidosis. Also Tang et al. [42] found that BAL alone
revealed positive malignant cells in 18 of 37 cases (sensitivity
48.6%) and the diagnostic value signiﬁcantly increased to
73.0% with combined BAL and TBLB techniques. In contrast
to this study, Zaman et al. [43] found that BAL was positive in
88.5% of cases of pulmonary sarcoidosis.
In this study, mucosal biopsy was diagnostic in 71.4% of
malignant patients, 66.7% of sarcoidosis patients and 100%
of TB patients. TBNA was diagnostic in 50% of malignant
patients and 66.7% of TB patients while BAL was diagnostic
in 28.6% of malignant patients. The combination of mucosal
biopsy and TBNA increased the percentage of diagnosed
malignancy patients to 78.6% while the combination of muco-
sal biopsy and BAL does not increase the diagnostic value.
Also the combination of TBNA and BAL does not add any
value to diagnoses by TBNA alone. The combination of muco-
sal biopsy, TBNA and BAL was equal to diagnostic value of
the combination of mucosal biopsy and TBNA.The present study concluded that bronchial mucosal biopsy
was the most important in diagnoses (56.7%) followed by
TBNA (30%) and ﬁnally BAL (13.3%). The best results
(60%) were obtained by combination of bronchial mucosal
biopsy and TBNA, while BAL had no added value. AFB
has little cost effective value over WLB in cases of mediastinal
lymphadenopathy. It is recommended to perform mucosal
biopsy in all patients with mediastinal lymphadenopathy, even
if the mucosa appears grossly normal. If TBNA is not avail-
able mucosal biopsy alone can yield a diagnosis. TBNA is best
combined with mucosal biopsy to improve the diagnostic yield.
BAL is not recommended to be performed routinely in combi-
nation with TBNA and mucosal biopsy in cases with medias-
tinal lymphadenopathy. It is better to perform EBUS guided
TBNA for more accurate lymph node sampling and to
improve the diagnostic yield of TBNA. Finally to validate
these recommendations it is better to perform this study on a
larger number of patients and in multi-centres.
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